{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:14Z","timestamp":1786982114365,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11883-016-0567-4","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T13:34:58Z","timestamp":1455802498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Epigenetics and Peripheral Artery Disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Jonathan","family":"Golledge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Biros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti M.","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"key":"567_CR1","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms160511294","volume":"16","author":"SM Krishna","year":"2015","unstructured":"Krishna SM, Moxon JV, Golledge J. A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16:11294\u2013322.","journal-title":"Int J Mol Sci"},{"key":"567_CR2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/HCO.0b013e328330c2d3","volume":"24","author":"J Golledge","year":"2009","unstructured":"Golledge J, Norman PE. Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients\u2019 management. Curr Opin Cardiol. 2009;24:532\u20138.","journal-title":"Curr Opin Cardiol"},{"key":"567_CR3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(97)07421-7","volume":"350","author":"J Golledge","year":"1997","unstructured":"Golledge J. Lower-limb arterial disease. Lancet. 1997;350:1459\u201365.","journal-title":"Lancet"},{"key":"567_CR4","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J Golledge","year":"2006","unstructured":"Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"567_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/03008200701331524","volume":"48","author":"PE Norman","year":"2007","unstructured":"Norman PE, Davis TM, Le MT, Golledge J. Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res. 2007;48:125\u201331.","journal-title":"Connect Tissue Res"},{"key":"567_CR6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/ATVBAHA.110.206573","volume":"30","author":"J Golledge","year":"2010","unstructured":"Golledge J, Norman PE. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol. 2010;30:1075\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"567_CR7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.amjcard.2014.06.029","volume":"114","author":"M Khaleghi","year":"2014","unstructured":"Khaleghi M, Isseh IN, Bailey KR, Kullo IJ. Family history as a risk factor for peripheral arterial disease. Am J Cardiol. 2014;114:928\u201332. This is one of the few studies to assess the association of family history with lower limb atherosclerosis associated occlusive disease and reported an odds ratio of 2.2.","journal-title":"Am J Cardiol"},{"key":"567_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2010.02.008","volume":"212","author":"SM Krishna","year":"2010","unstructured":"Krishna SM, Dear AE, Norman PE, Golledge J. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. Atherosclerosis. 2010;212:16\u201329.","journal-title":"Atherosclerosis"},{"key":"567_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20140491","volume":"128","author":"SM Krishna","year":"2015","unstructured":"Krishna SM, Trollope AF, Golledge J. The relevance of epigenetics to occlusive cerebral and peripheral arterial disease. Clin Sci (Lond). 2015;128:537\u201358.","journal-title":"Clin Sci (Lond)"},{"key":"567_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2013.02.019","volume":"228","author":"SM Krishna","year":"2013","unstructured":"Krishna SM, Dear A, Craig JM, Norman PE, Golledge J. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis. 2013;228:295\u2013305.","journal-title":"Atherosclerosis"},{"key":"567_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1024\/0301-1526\/a000345","volume":"43","author":"W Kloos","year":"2014","unstructured":"Kloos W, Vogel B, Blessing E. MiRNAs in peripheral artery disease\u2014something gripping this way comes. Vasa. 2014;43:163\u201370.","journal-title":"Vasa"},{"key":"567_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/15701611113119990015","volume":"13","author":"M Adam","year":"2015","unstructured":"Adam M, Raaz U, Spin JM, Tsao PS. MicroRNAs in Abdominal Aortic Aneurysm. Curr Vasc Pharmacol. 2015;13:280\u201390.","journal-title":"Curr Vasc Pharmacol"},{"key":"567_CR13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HCO.0b013e32835f0d55","volume":"28","author":"J Golledge","year":"2013","unstructured":"Golledge J, Kuivaniemi H. Genetics of abdominal aortic aneurysm. Curr Opin Cardiol. 2013;28:290\u20136.","journal-title":"Curr Opin Cardiol"},{"key":"567_CR14","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.3390\/ijms160511276","volume":"16","author":"R Spear","year":"2015","unstructured":"Spear R, Boytard L, Blervaque R, Chwastyniak M, Hot D, Vanhoutte J, et al. Adventitial tertiary lymphoid organs as potential source of microRNA biomarkers for abdominal aortic aneurysm. Int J Mol Sci. 2015;16:11276\u201393. This study used laser microdissection to look at MicroRNAs expressed in human AAA associated lymphoid tissue.","journal-title":"Int J Mol Sci"},{"key":"567_CR15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvs.2013.02.244","volume":"59","author":"BL Cheuk","year":"2014","unstructured":"Cheuk BL, Cheng SW. Identification and characterization of microRNAs in vascular smooth muscle cells from patients with abdominal aortic aneurysms. J Vasc Surg. 2014;59:202\u20139.","journal-title":"J Vasc Surg"},{"key":"567_CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/bjs.9802","volume":"102","author":"PW Stather","year":"2015","unstructured":"Stather PW, Sylvius N, Sidloff DA, Dattani N, Verissimo A, Wild JB, et al. Identification of microRNAs associated with abdominal aortic aneurysms and peripheral arterial disease. Br J Surg. 2015;102:755\u201366. This study identifies a number of circulating MicroRNAs associated with AAA and lower limb occlusive artery disease.","journal-title":"Br J Surg"},{"key":"567_CR17","doi-asserted-by":"crossref","first-page":"e000745","DOI":"10.1161\/JAHA.112.000745","volume":"1","author":"K Kin","year":"2012","unstructured":"Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K, Shimamura K, et al. Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc. 2012;1:e000745.","journal-title":"J Am Heart Assoc"},{"key":"567_CR18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1042\/CS20130599","volume":"126","author":"E Biros","year":"2014","unstructured":"Biros E, Moran CS, Wang Y, Walker PJ, Cardinal J, Golledge J. microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clin Sci (Lond). 2014;126:795\u2013803. miR-155 was identified as upregulated within aortic biopsies of human AAA and also serum of patients that had AAAs.","journal-title":"Clin Sci (Lond)"},{"key":"567_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1755-8794-5-25","volume":"5","author":"MC Pahl","year":"2012","unstructured":"Pahl MC, Derr K, G\u00e4bel G, Hinterseher I, Elmore JR, Schworer CM, et al. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics. 2012;5:25.","journal-title":"BMC Med Genomics"},{"key":"567_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2010.09.029","volume":"412","author":"T Li","year":"2011","unstructured":"Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta. 2011;412:66\u201370.","journal-title":"Clin Chim Acta"},{"key":"567_CR21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.clinbiochem.2015.04.016","volume":"48","author":"W Zhang","year":"2015","unstructured":"Zhang W, Shang T, Huang C, Yu T, Liu C, Qiao T, et al. Plasma microRNAs serve as potential biomarkers for abdominal aortic aneurysm. Clin Biochem. 2015;48:988\u201392. Three plasma microRNAs (miR-191-3p, miR-455-3p and miR-1281) were identified as having good sensitivity and specificity in identifying patients with AAA.","journal-title":"Clin Biochem"},{"key":"567_CR22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1161\/ATVBAHA.114.305048","volume":"35","author":"S Dangwal","year":"2015","unstructured":"Dangwal S, Stratmann B, Bang C, Lorenzen JM, Kumarswamy R, Fiedler J, et al. Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines. Arterioscler Thromb Vasc Biol. 2015;35:1480\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"567_CR23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/CIRCGENETICS.111.000053","volume":"6","author":"PW Stather","year":"2013","unstructured":"Stather PW, Sylvius N, Wild JB, Choke E, Sayers RD, Bown MJ. Differential microRNA expression profiles in peripheral arterial disease. Circ Cardiovasc Genet. 2013;6:490\u20137. This study identified a number of microRNAs with good diagnostic ability for lower limb arterial occlusive disease as judged by receiver operator characteristic curves.","journal-title":"Circ Cardiovasc Genet"},{"key":"567_CR24","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/ncomms6214","volume":"5","author":"L Maegdefessel","year":"2014","unstructured":"Maegdefessel L, Spin JM, Raaz U, Eken SM, Toh R, Azuma J, et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun. 2014;5:5214. This study suggests that miR-24 inhibits AAA within a mouse model.","journal-title":"Nat Commun"},{"key":"567_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/CIRCRESAHA.115.304361","volume":"115","author":"A Zampetaki","year":"2014","unstructured":"Zampetaki A, Attia R, Mayr U, Gomes RS, Phinikaridou A, Yin X, et al. Role of miR-195 in aortic aneurysmal disease. Circ Res. 2014;115:857\u201366.","journal-title":"Circ Res"},{"key":"567_CR26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/ATVBAHA.113.303134","volume":"34","author":"CW Kim","year":"2014","unstructured":"Kim CW, Kumar S, Son DJ, Jang IH, Griendling KK, Jo H. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler Thromb Vasc Biol. 2014;34:1412\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"567_CR27","doi-asserted-by":"crossref","first-page":"122ra22","DOI":"10.1126\/scitranslmed.3003441","volume":"4","author":"L Maegdefessel","year":"2012","unstructured":"Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med. 2012;4:122ra22.","journal-title":"Sci Transl Med"},{"key":"567_CR28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI61598","volume":"122","author":"L Maegdefessel","year":"2012","unstructured":"Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest. 2012;122:497\u2013506. This study confirms that miR-29b limits AAA within multiple mouse models.","journal-title":"J Clin Invest"},{"key":"567_CR29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCRESAHA.111.255737","volume":"109","author":"RA Boon","year":"2011","unstructured":"Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. 2011;109:1115\u20139.","journal-title":"Circ Res"},{"key":"567_CR30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","volume":"110","author":"DR Merk","year":"2012","unstructured":"Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, et al. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res. 2012;110:312\u201324.","journal-title":"Circ Res"},{"key":"567_CR31","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jcmm.12586","volume":"19","author":"Z Lei","year":"2015","unstructured":"Lei Z, van Mil A, Brandt MM, Grundmann S, Hoefer I, Smits M, et al. MicroRNA-132\/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway. J Cell Mol Med. 2015;19:1994\u20132005.","journal-title":"J Cell Mol Med"},{"key":"567_CR32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/CIRCULATIONAHA.114.014579","volume":"131","author":"F Pankratz","year":"2015","unstructured":"Pankratz F, Bemtgen X, Zeiser R, Leonhardt F, Kreuzaler S, Hilgendorf I, et al. MicroRNA-155 exerts cell-specific antiangiogenic but proarteriogenic effects during adaptive neovascularization. Circulation. 2015;131:1575\u201389.","journal-title":"Circulation"},{"key":"567_CR33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/CIRCRESAHA.114.304747","volume":"115","author":"SM Welten","year":"2014","unstructured":"Welten SM, Bastiaansen AJ, de Jong RC, de Vries MR, Peters EA, Boonstra MC, et al. Inhibition of 14q32 microRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res. 2014;115:696\u2013708. This study suggests that gene silencing oligonucleotides targeted on 14q32 expressed microRNAs stimulate arteriogenesis in a mouse model of hind limb ischemia.","journal-title":"Circ Res"},{"key":"567_CR34","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1038\/srep03883","volume":"4","author":"Y Endo-Takahashi","year":"2014","unstructured":"Endo-Takahashi Y, Negishi Y, Nakamura A, Ukai S, Ooaku K, Oda Y, et al. Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia. Sci Rep. 2014;4:3883.","journal-title":"Sci Rep"},{"key":"567_CR35","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.112.000860","volume":"127","author":"S Hazarika","year":"2013","unstructured":"Hazarika S, Farber CR, Dokun AO, Pitsillides AN, Wang T, Lye RJ, et al. MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway. Circulation. 2013;127:1818\u201328.","journal-title":"Circulation"},{"key":"567_CR36","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1093\/eurheartj\/eht041","volume":"35","author":"J Semo","year":"2014","unstructured":"Semo J, Sharir R, Afek A, Avivi C, Barshack I, Maysel-Auslender S, et al. The 106b\u223c25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice. Eur Heart J. 2014;35:3212\u201323.","journal-title":"Eur Heart J"},{"key":"567_CR37","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M112.364414","volume":"287","author":"KJ Yin","year":"2012","unstructured":"Yin KJ, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE. Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem. 2012;287:27055\u201364.","journal-title":"J Biol Chem"},{"key":"567_CR38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710\u20133.","journal-title":"Science"},{"key":"567_CR39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvr227","volume":"92","author":"C Solingen van","year":"2011","unstructured":"van Solingen C, de Boer HC, Bijkerk R, Monge M, van Oeveren-Rietdijk AM, Seghers L, et al. MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)\/Lin(\u2212) progenitor cells in ischaemia. Cardiovasc Res. 2011;92:449\u201355.","journal-title":"Cardiovasc Res"},{"key":"567_CR40","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1582-4934.2008.00613.x","volume":"13","author":"C Solingen van","year":"2009","unstructured":"van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009;13:1577\u201385.","journal-title":"J Cell Mol Med"},{"key":"567_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/CS20150435","volume":"130","author":"SM Krishna","year":"2016","unstructured":"Krishna SM, Omer SM, Golledge J. Evaluation of the clinical relevance and limitations of current preclinical models of peripheral artery disease. Clin Sci. 2016;130:127\u201350.","journal-title":"Clin Sci"},{"key":"567_CR42","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.3390\/ijms160511259","volume":"16","author":"EJ Ryer","year":"2015","unstructured":"Ryer EJ, Ronning KE, Erdman R, Schworer CM, Elmore JR, Peeler TC, et al. The potential role of DNA methylation in abdominal aortic aneurysms. Int J Mol Sci. 2015;16:11259\u201375. This study looks as the association of DNA methylation patterns with AAA.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"567_CR43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cvr\/cvv160","volume":"107","author":"W Hu","year":"2015","unstructured":"Hu W, Wang M, Yin H, Yao C, He Q, Yin L, et al. MicroRNA-1298 is regulated by DNA methylation and affects vascular smooth muscle cell function by targeting connexin 43. Cardiovasc Res. 2015;107(4):534\u201345.","journal-title":"Cardiovasc Res"},{"key":"567_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000110041","volume":"45","author":"A Vinh","year":"2008","unstructured":"Vinh A, Gaspari TA, Liu HB, Dousha LF, Widdop RE, Dear AE. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J Vasc Res. 2008;45:143\u201352.","journal-title":"J Vasc Res"},{"key":"567_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2011.03.006","volume":"217","author":"J Golledge","year":"2011","unstructured":"Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011;217:57\u201363.","journal-title":"Atherosclerosis"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-016-0567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-016-0567-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-016-0567-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T09:34:50Z","timestamp":1654335290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-016-0567-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s11883-016-0567-4","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]},"article-number":"15"}}